Northbrook, Illinois-based The Allstate Corporation (ALL) provides property and casualty and other insurance products in the United States and Canada. The company has a market cap of $63.5 billion and operates in four segments: Allstate Protection; Run-off Property-Liability; Protection Services; and Corporate and Other. ALL is expected to release its Q3 2026 earnings on Wednesday, November 4, after the market closes.
Ahead of the event, analysts expect the company’s EPS to be $7.03 on a diluted basis, down 37.1% from $11.17 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
For fiscal 2026, analysts project the company’s EPS to be $36.21, up 4% from $34.83 in fiscal 2025. However, its EPS is expected to fall by roughly 20.4% year over year (YoY) to $28.84 in fiscal 2027.
www.barchart.com Allstate shares have surged 29.6% over the past 52 weeks, outperforming the S&P 500 Index’s ($SPX) 15.2% rise and the State Street Financial Select Sector SPDR ETF’s (XLF) 6.3% rise during the same time frame.
www.barchart.com Analysts are fans of ALL’s strong fundamentals, which helped it outperform over the past year. The company’s pre-tax profit margin grew by 18.4% over the last two years, as it scaled and became more efficient. Moreover, its annual earnings per share grew by 83.7% over the past two years, exceeding its revenue gains and also contributing to share repurchases, strengthening its shareholder returns. Moreover, ALL’s annual book value per share growth of 40.9% over the last two years was impressive, which also points to the company’s capital strength increasing during that time frame.
Analysts are somewhat bullish on ALL, with the stock having a “Moderate Buy” rating overall. Among the 25 analysts covering the stock, 10 suggest a “Strong Buy,” 11 suggest a “Hold,” one recommends a “Moderate Sell,” and three suggest a “Strong Sell” for the stock. Moreover, ALL’s average analyst price target of $270.74 indicates a 7.8% upside from current levels.
On the date of publication, Aritra Gangopadhyay did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.